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Background: The diagnosis of the leishmaniases poses enormous challenges in Argentina. The Polymorphism-
Specific PCR (PS-PCR) designed and validated in our laboratories has been proven effective for typifying the
Leishmania genus from cultured material. Here we evaluated the performance of this method in the diagnosis of
American tegumentary leishmaniasis (ATL) and the rapid identification of Leishmania spp. directly from clinical
specimens.
Methods: A total of 63 patients from northwestern Argentina, with cutaneous or mucocutaneous lesions,
underwent an ATL diagnosis protocol which included clinical examination, Leishmanin skin test, and microscopic
examination of dermal smears. In addition, we performed PS-PCR on DNA directly extracted from the specimens
scraped from the lesions.
Results: Out of the 63 patients, 44 were classified as ATL cases and 19 as non-ATL cases. The diagnostic sensitivity
of the microscopic analysis of dermal smears and PS-PCR individually were 70.5% and 81%, respectively. When
performing both tests in parallel, this parameter increased significantly to 97.6% (p = 0.0018). The specificities, on
the other hand, were 100%, 84.2%, and 83.3% for the combination, respectively (p > 0.05). Using the PS-PCR
analysis we successfully identified the Leishmania spp. in 31 out of the 44 ATL cases. Twenty-eight (90.3%) cases
were caused by L. (V.) braziliensis, two (6.5%) by L. (V.) guyanensis, and one (3.2%) by L. (V.) panamensis.
Conclusions: The efficacy of the ATL diagnosis was significantly improved by combining the dermal smear
examination with a PS-PCR analysis. Our strategy allowed us to reach the diagnosis of ATL with high accuracy
regarding the species of the etiological agent in 70.5% of the cases. Moreover, we diagnosed two cases of the
disseminated cutaneous form caused by L. (V.) braziliensis and a cutaneous case due to L. (V.) panamensis infection,
both findings reported for the first time in Argentina.
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The leishmaniases are a group of neglected tropical dis-
eases caused by flagellated parasites of the genus Leish-
mania. According to the World Health Organization
(WHO), they remain as category I TDR diseases, signify-
ing their status as emerging and uncontrolled, and high-
lighting the need for new and better tools for their
diagnosis, treatment and prevention [1].
American tegumentary leishmaniasis (ATL) is endemic
in Argentina with an estimated incidence of 8.76 cases/
year/106 inhabitants, calculated from 1984 to 2005 [2].
However, these data might not be accurate since the la-
boratory resources for confirming ATL are not always
available, and local physicians have to report suspected
cases merely based on clinical evidence without any diag-
nostic test. Furthermore, the visualization of amastigotes
in smears prepared with material scraped from lesions,
requires highly trained personnel, is time consuming, and
often shows low sensitivity [3]. In the north of Salta prov-
ince, where 53.1% of all cases reported in the Argentina
occur, some institutions enforce applying the Montenegro
skin test (MST) together with microscopic examination of
smears to diagnose ATL. Although MST detects past
infections or previous contact with the parasite, it is a use-
ful tool for screening or as a complementary test for the
diagnosis of an active disease [4].
Leishmania species identification, very important for
prescribing the appropriate treatments and evaluating
the prognosis, is mainly performed for research purpose,
and is rarely applied in clinical practice in Argentina. In
a previous work, applying multilocus enzyme electro-
phoresis (MLEE), we determined that Leishmania (Vian-
nia) braziliensis was the prevalent species causing three
different clinical forms of ATL: cutaneous (CL), mucocu-
taneous (MCL), and recurrent cutaneous leishmaniasis
in Salta province. Leishmania (Leishmania) amazonensis
and L. (V.) guyanensis were also isolated from patients
with CL from this area, however only few isolates were
specifically characterized so far [4,5].
Considering the presence of several dermatological
diseases with similar clinical manifestations to ATL, the
reduced applicability of serological diagnostic methods
because of their cross reactivity with American trypano-
somiasis [6] , and the presence of at least three Leish-
mania spp. in the area, techniques based on the DNA
analysis have been developed as alternative approaches
for the diagnosis of ATL and the typing of the Leish-
mania genus [7]. Among them, the polymorphism-
specific PCR (PS-PCR) has been established in our
laboratories for the identification of the five main spe-
cies responsible for ATL [8]. Moreover, this procedure
was validated against MLEE, the gold standard method,
using Leishmania isolates from local patients cultured
in vitro [9].In the present study we evaluated the performance of
a modified PS-PCR approach applied directly on clinical
samples. Our results demonstrate that the method read-
ily permits the detection and species identification of
parasites causing ATL in Argentina. Furthermore, we be-
lieve that using this approach might have an impact on




All patients voluntarily requested the tests for the differ-
ential diagnosis of their lesions, and consented to par-
ticipate anonymously in this study. The procedures were
approved by the Bioethics Committee of the Health
Ministry of Salta, Argentina, and followed the Declar-
ation of Helsinki Principles.
Patients and diagnosis
Sixty-three patients with cutaneous or mucocutaneous
lesions suspected of leishmaniasis were included in this
study. Patients were diagnosed in three different institu-
tions; the Research Institute of Tropical Diseases, Uni-
versity of Salta, Oran; the Department of Dermatology,
Milagro Hospital; and the Department of Dermatology
and Otorhinolaryngology, San Bernardo Hospital. All of
them are located in Salta, Argentina.
The diagnosis of ATL was performed using a combin-
ation of the three criteria currently applied in this area,
and described as follows:
Parasitological analysis
Search for Leishmania amastigotes was done on smears
of dermal scrapings from the border of the lesions,
obtained with sterile wooden toothpicks, stained with
May-Grunewald Giemsa and examined under a micro-
scope as described previously [10].
Montenegro skin test
Leishmanin antigen was prepared from a culture of
L. (V.) braziliensis strain MHOM/AR/03/OLO1, follow-
ing previously described protocols [4,5]. Four μg (100 μl)
of total promastigotes proteins were injected intrader-
mally on the ventral forearm of the patients. Readings
were taken 48 hours after the injections, and indurations
measuring ≥ 5 mm in diameter were considered reactive
[4].
Clinical features
The inclusion criterion was the presence of compatible
tegumentary injuries, which included ulcerative, nodu-
lous, papulous cutaneous or mucocutaneous lesions of
two or more weeks of evolution, and a congruent epi-
demiological history. Previous diagnoses of CL were
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cases.
All patients diagnosed in the present work as ATL
cases were systemically treated with 10–20 mg d−1 kg
body wt−1 of pentavalent antimony over 25–30 days. In
the cases of incomplete clinical cure, another treatment-
cycle of the same extension with antimony or amphoter-
icin B was given. The treatments and clinical follow-up
were conducted by local physicians.
DNA samples for PCR assays
Specimens were obtained by scrapping the edge of the
lesions with sterile wooden toothpicks and placed in a
tube containing 200 μl of TE buffer. The material was
heated in a waterbath at boiling temperature for 10 min
and then stored at −20°C [11]. DNA was extracted with a
phenol-chloroform mixture, precipitated with ethanol and
dissolved in 20 μl of TE buffer. A titration assay showed
that a 1/20 DNA dilution was optimal for the PS-PCR
analyses. Furthermore, the detection limit of the reaction
was estimated in 0.3 ng/μl of total Leishmania DNA.
Four Leishmania strains, MHOM/AR/03/OLO1 of L.
(V.) braziliensis, MHOM/AR/99/JDM1 of L. (V.) guya-
nensis, MHOM/PA/71/LS94 of L. (V.) panamensis, and
MHOM/BR/73/M2269 of L. (L.) amazonensis, were used
as controls. Their DNA was extracted from promasti-
gotes cultures according to described protocols [5,12],
and purified using the GenomicPrep Cell and Tissue
DNA Isolation Kit (Amersham Biosciences, NJ) follow-
ing the manufacturer’s instructions. The DNA concen-
trations were determined in a NanoDrop ND-1000
spectrophotometer (NanoDrop Technologies, Wilming-
ton, DE), and adjusted to 10 ng/μl with Milli Q water.
Polymorphism-specific PCR
This analysis took into account of the genomic differences
among species of the Leishmania genus. We first per-
formed Arbitrarily-Primed-PCR on total DNA from the five
most prevalent species associated with ATL and sequenced
those DNA fragments present in single species to design
the primers addressing these polymorphisms. In addition,








GAPDH 50-CGGGAAGCTTGTGATCAATGG-30in order to have the necessary specificity for each reac-
tion [8]. The reactions were performed in duplicate in a
GeneAmp PCR System 2400 (Perkin Elmer, Wellesley,
MA) using the Roche GeneAmp XL PCR Kit (Applied
Biosystems, Foster City, CA) in 15 μl final volume.
The PS-PCR procedure involved two steps; the first
was aimed at the ATL diagnosis and also the identifica-
tion of Leishmania subgenus or Leishmania complexes.
It consists of two reactions, A and B, performed simul-
taneously in two separate tubes. Reaction A was done
with the primers V1-V2, specific for the Viannia sub-
genus (Table 1), under the conditions previously
reported [9]. Reaction B was performed with the primers
M1-M2 for the detection of L. mexicana and L. dono-
vani complexes belonging to the Leishmania subgenus
[13], under the following conditions: initial denaturation
at 94°C for five minutes, 35 cycles (30 sec at 94°C, one
minute at 60°C, one minute at 72°C), and a final exten-
sion step at 72°C for seven minutes) [14].
The second step addressed the identification of Leish-
mania species. The reactions were performed with three
different sets of primers, b1-b2 for L. (V.) braziliensis, p1-
p2 for L. (V.) panamensis and g1-g2 for L. (V.) guyanensis
on DNA which gave the expected products with primers
V1-V2, under conditions previously reported [9].
If a sample resulted positive for reaction B, it was
assayed again with the same M1-M2 primers, but at
67.5°C or 72°C annealing temperature, which are specific
for L. mexicana complex and L. (L.) amazonensis, re-
spectively [14].
DNA extracted from Leishmania promastigotes cultured
in vitro or from confirmed ATL patients was used as a
positive control, whereas DNA of eight healthy individuals
from non-endemic area (Japanese subjects) or from lesions
of non-ATL patients was used as negative control.
Additional experiments to control the DNA prepar-
ation procedure, as well as to detect the presence of
PCR inhibitors were performed using the TaKaRa Ex
Taq DNA polymerase Hot Start Version (Takara-Bio,
Shiga, Japan) and specific primers for the human glycer-
aldehydes 3-phosphate dehydrogenase (GAPDH) gene,









Figure 1 Disseminated cutaneous leishmaniasis. A patient with
multiple ulcerated lesions of different degrees of evolution found on
hands (A) and legs (B). Leishmania amastigotes were found in
smears from the most recent lesions located on hands, face and the
back of the patient. The lesions present in legs were the oldest. The
Montenegro skin test was reactive, and L. (V.) braziliensis was
incriminated as the causative agent by PS-PCR.
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taining ethidium bromide, visualized under UV light and
the results were recorded with a Kodak EDAS 290 gel
documentation system (Kodak, Rochester, NY).
Statistical analysis
The diagnostic performance of the tests alone or com-
bined was assessed by calculating several statistical indica-
tors, including sensitivity, specificity and predictive values.
First the patients were classified into two groups: ATL
cases and non-ATL cases based on the presence or ab-
sence of the disease. Then the results of the PS-PCR
method for each patient were added to the tables and
analyzed independently of the ATL group definition. The
sensitivity, specificity, predictive values, and the Cohen’s
kappa coefficient were estimated applying Epidat 3.1 soft-
ware (Pan American Health Organization, Spain) [16].
The predictive values for the laboratory were calculated
by applying the Theorem of Bayes assuming a prevalence
of 54.82% for the year 2005 with the same software. The
proportions were compared by Statistic-z analysis or the
Fisher’s exact test [16]. The positive and negative PCR
controls, or results from non-endemic healthy controls
were not included in any of these calculations.
Results
The study included 63 patients; eight females (12.7%)
and fifty five males (87.3%), with a mean age of 39.6 ±
17.4 years (mean ± standard deviation). High variability
in terms of the number, size and evolution-time was
observed, skin-lesions measured 2.9 ± 1.7 cm in diam-
eter, and evolved over 2.2 ± 1.8 months, while the
progression-time of lesions located on oropharyngeal
mucosa was 26.4 ± 22.8 months. Regarding to their dis-
tribution, in 30 patients (47.6%) skin lesions were
located on the extremities, and in 24 subjects (38.1%)
they were located on the head, including 11 (17.5%)
patients with mucocutaneous injuries. Two patients
(3.2%) had lesions on the trunk. In addition, five patients
(7.9%) presented lesions on two different parts of their
bodies, and two patients (3.2%) had more than 30 lesions
distributed all over their bodies, including the oropha-
ryngeal mucosae (Figure 1). Out of 43 patients who sta-
ted their employment situation during the clinical
examination, 24 (55.8%) were rural workers, six (13.9%)
were unemployed and four (6.3%) were housekeepers.
The diagnosis of ATL was based on the clinical fea-
tures, the parasitological analysis, and the results of MST,
applied simultaneously to each patient. The parasito-
logical method was considered the gold-standard, mean-
ing that the visualization of Leishmania amastigotes in
the smears indicates presence of the disease. Out of the
63 patients with cutaneous or mucosal lesions, 44 (69.8%)
were diagnosed as ATL-cases, whereas the remaining 19
Table 2 Results of smear and PS-PCR individually, or
combined in parallel, applied to 63 patients
ATL
Assay Result Presence Abscence1 Total
Smear Positive 31 0 31
Negative 13 18 31
Total 44 182 62
PS-PCR Positive 34 3 37
Negative 8 16 24
Total 423 19 61
Smear + PS-PCR Positive 41 3 44
Negative 1 15 16
Total 42 18 60
ATL = American tegumentary leishmaniasis. 1Determined by the criterion
mentioned in text. 2One out of 19 non-ATL cases was not considered for the
analysis because cells were not observed in the smear. 3Insuficient DNA was
obtained from two samples out of 44 ATL cases.
Marco et al. BMC Infectious Diseases 2012, 12:191 Page 5 of 8
http://www.biomedcentral.com/1471-2334/12/191were classified as non ATL-cases, the group representing
absence of the disease (Table 2). It is noteworthy that
patients with negative parasitological examinations were
considered as ATL-cases only if they presented a reactive
MST in addition to consistent clinical features and a con-
gruent epidemiological history. Thus, the 19 patients who
formed the non-ATL group shared negative results for
both parasitological and MST methods.
Performance of PS-PCR in the diagnosis of American
tegumentary leishmaniasis
DNA extracted from the material scrapped from the
lesions of the 63 patients was subjected to PS-PCR ana-
lysis. Primers V1-V2 were used for the identification of
the Viannia subgenus and M1-M2 for L. mexicana andFigure 2 PCR-based diagnosis and Leishmania species assignation. PC
Viannia subgenus identification. Lanes 1, 4, 5, 8, 9 and 13 were positives, an
negative and positive control, respectively (A). PCR using M1-M2 primers fo
Lanes 1 to 5 were negatives. Lanes 6 and 7 negative and positive control, r
b1-b2 (b), g1-g2 (g) and p1-p2 (p) specific for L. (V.) braziliensis, guyanensis
g and p = negatives. Patient 2: g = positive, b and p = negatives. Patient 3
positive control, respectively. M: marker of molecular weight. Arrows indicaL. donovani complexes. The analysis with primers V1-V2
showed that 34 ATL patients were infected with para-
sites belonging to the Viannia subgenus (Table 2,
Figure 2A). Whereas PCRs with primers M1-M2 did not
yield any amplification product at 60°C (Figure 2B), an
annealing temperature proved effective in detecting all
species of the Leishmania subgenus responsible for ATL
or New World visceral leishmaniasis [14].
Amastigotes were observed in 31samples from ATL
patients (Table 2), whereas PS-PCR demonstrated the
presence of parasites in 34 samples. By combining both
methods we were able to accurately diagnose 41 out of
the 44 ATL cases. These results were used to calculate
indicators of the diagnostic performance shown in
Table 3. Microscopic detection of parasites possesses, by
definition, the highest diagnostic specificity, whereas the
molecular method exhibits more sensitivity than the
former. Interestingly, the combination of approaches in
parallel increased substantially the diagnostic sensitivity.
It is noteworthy that a positive result for the combin-
ation implies that either the smear or PS-PCR was posi-
tive, whereas a negative result implies negativity with
both of them [16]. Statistical analysis also demonstrated
that there is a fair agreement between PS-PCR and
smear (Cohen’s kappa coefficient = 0.237 ± 0.113).
The PS-PCR has shown a significant higher sensitiv-
ity than smears for the diagnosis of MCL. Among nine
patients with this clinical form, eight were found posi-
tive by PS-PCR, while only two by smear observation
(p < 0.05).
Control PCRs with primers for the human GAPDH
gene demonstrated that the sampling and purification
steps of the protocol were effective and also that the
samples were devoid of PCR inhibitors. However, weakR products from 12 samples from patients using V1-V2 primers for
d lanes 2, 3, 10, 11, 12 and 14 were negatives. Lanes 6 and 7 are the
r L. mexicana and L. donovani complexes applied to five DNA samples.
espectively (B). Species identification by PCR analysis with primers
and panamensis, respectively (C). Patient 1: Lane b = positive,
: p = positive, b and g = negatives. Lanes 4 and 5, negative and
te the expected location of the bands.
Table 3 Performance of smears and PS-PCR analyses, and
their combination, in the diagnosis of ATL
Assay Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Smear 70.5 100 99.9 73.6
PS-PCR 81 84.2 86.2 78.5
Smear + PS-PCR 97.61 83.3 87.9 91
PPV = positive predictive values; NPV = negative predictive values, estimated
applying the theorem of Bayes. The positive and negative PCR controls and
the results from healthy individuals from non-endemic areas were not
included in the calculations.1The differences between proportions were
statistically significant (P = 0.0018) when the Smear + PS-PCR were compared
against these tests alone.
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most likely due to low DNA concentration. Since these
samples did not give conclusive results with V1-V2 and
M1-M2 primers, they have not been considered for cal-
culations of the sensitivity and the positive predictive
values (Table 2).
Identification of Leishmania species by PS-PCR
The total of 34 samples in which we detected parasites
of the subgenus Viannia (see above, Table 2) were sub-
jected to PCR analyses using the primers b1-b2, g1-g2
and p1-p2. The identification of Leishmania spp. was
achieved in 31 out of these 34 samples, which represents
70.5% of all 44 ATL cases studied (Figure 2C). Leish-
mania (V.) braziliensis was identified as the etiological
agent in 28 ATL cases, which included the four clinical
forms of the disease: single cutaneous leishmaniasis
(SCL), multiple cutaneous leishmaniasis (MultCL), disse-
minated cutaneous leishmaniasis (DSCL), and MCL,
whereas L. (V.) panamensis and L. (V.) guyanensis were
implicated in one and two ATL cases, respectively
(Table 4).
The patients with DSCL, caused by L. (V.) braziliensis,
had more than 30 lesions each, distributed throughout
the body, compromising face, abdomen, extremities,
back, and oro-nasal mucosae. The lesions showed differ-
ent degrees of evolution, from the early papular to the
predominant ulcerated form, developing within a two
month period following the appearance of the single cu-
taneous lesion (Figure 1). Leishmania amastigotes wereTable 4 Leishmania species identified by PS-PCR causing
ATL in NW Argentina
Leishmania spp. Prevalence Total
(%)SCL MultCL DSCL MCL
L. (V.) braziliensis 15 4 2 7 28 (90.3)
L. (V.) guyanensis - 2 - - 2 (6.5)
L. (V.) panamensis 1 - - - 1 (3.2)
L. mexicana or donovani complex - - - - 0 (−)
ATL = American tegumentary leishmaniasis; SCL = single cutaneous
leishmaniasis; MultCL = multiple cutaneous leishmaniasis; DSCL =
disseminated cutaneous leishmaniasis; MCL = mucocutaneous leishmaniasis.found in the smears from several lesions and the MST
was reactive in all cases. All these patients responded
well to the antimonial treatment.Discussion
The development and/or improvement of diagnostic
tools remain a priority in the research field of leishman-
iasis. In particular, much work has to be done for in-
creasing the sensitivity and specificity of the diagnostic
tests for ATL in endemic areas, such as NW Argentina
[1]. In this work, we assessed both the impact of adding
a PS-PCR analysis to the diagnosis-methods currently
used in Argentina, and its usefulness to the identification
of the causal-agent of the disease at the species level.
Indeed, by performing PS-PCR directly on clinical
samples, we enhanced significantly the efficacy of the
ATL diagnosis, especially for MCL. Appling this method
to patients with negative results for the microscopic
search of parasites in dermal smears, allowed us to in-
crease substantially the diagnostic sensitivity from 70.5%
for smears alone to 97.6% for the combination (Table 3).
Thus, these results confirm that the PCR analysis is a
valuable and applicable strategy for these cases of sus-
pected ATL with negative microscopic examination. The
relevance of this strategy becomes apparent when con-
sidering the availability of effective treatments or the
tendency of the disease to evolve into severe clinical
forms if left untreated. These factors indicate that the
sensitivity of the diagnostic method should have the pri-
ority for maximization, rather than its specificity [17].
Previous PCR analyses for the diagnosis of leishmaniases
displayed sensitivities ranging from 51.7% to 100% [18-20].
This wide variability in the sensitivity may very well be
due to the methods employed, but also attributable to
differences in the sampling techniques, or the clinical
and laboratory criteria applied for defining the presence
or absence of the disease [7]. The sensitivity of the PS-
PCR analysis estimated in this study (81%) is in close
agreement with those reported by other investigators
when the method was performed on samples from cuta-
neous lesions of patients with ATL from endemic areas
of Ecuador [21,22]. Among the reasons for false negative
PS-PCR results, the low parasite burden observed in the
borders of the lesions might be of importance. Therefore,
improving the sampling method, for example, using a
syringe to aspirate the sample or collecting the exudates
after scraping the lesions, in addition to efficient DNA
extraction, would appear to substantially increase sensi-
tivity and diagnostic efficacy [22].
In the present work, three non-ATL cases were PS-
PCR positive, lowering the specificity to 84.2%. Since
these patients presented atypical lesions, and were nega-
tive for the microscopic parasitological examination and
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contamination of the DNA sample.
An identification of Leishmania spp. with PS-PCR ap-
plied directly on material scrapped from the lesions was
achieved in 70.5% of ATL cases. Leishmania (V.) brazi-
liensis was the most prevalent species (90.3%) among
ATL patients, and this is consistent with previous stud-
ies aimed to characterize Leishmania stocks isolated in
NW Argentina [5,23]. Since we performed the analysis
on samples collected directly from the lesions, the indi-
cators of species prevalence reported here might be
more accurate than those published before. Moreover,
the method has additional advantages, as it gives the
Leishmania spp. identification without further proce-
dures, such as digestion analysis of the PCR products or
gene sequencing, and it is applicable in relatively low-
resource laboratories.
Leishmania (V.) braziliensis was involved in two cases
DSCL reported for the first time in Argentina (Figure 1).
Local ATL cases due to L. (V.) guyanensis were also
found, confirming our previous report on the presence
of this species in this area [9]. These findings are of clin-
ical relevance for the patients, because they require a
different treatment, such as a protocol with pentamidine
rather than the pentavalent antimonials commonly pre-
scribed in this area [19,24]. Interestingly L. (V.) pana-
mensis was identified in one sample (Figure 2C). This is
the first case reported in Argentina. Although parasites
belonging to the Leishmania mexicana or donovani
complexes were found involved in cases of leishmaniasis
in this area [4,25], we could not prove their involvement
in the present series (Table 4).
Conclusions
In conclusion, by adding the PS-PCR method to the pro-
cedures commonly applied in the country, we improved
the diagnostic performance of ATL. The strategy also
allowed the identification of Leishmania spp. in the vast
majority of the cases without isolation of the parasites
in vitro.
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